Important dates:
March 15, 2022 Abstract Submission Open. There are limited numbers of oral highlight presentation spots. Authors are encouraged to submit early to maximize opportunity for oral highlight selection.
May 27, 2022 Final abstract submission deadline.
Abstracts will be reviewed on a rolling basis with acceptance decisions provided as early as 3 days within submission. Decision on oral highlight selection may be provided at the same time as abstract acceptance or a later date. All acceptance decisions will be made on or before June 8, 2022. Decisions are made by the Abstract Committee and are final. Submitters will not necessarily be provided technical feedback or rationale for decisions.
All abstracts will be reviewed under confidentiality. Once accepted Abstracts may be published. By submitting an Abstract, all authors agree to the content being immediately published if they are accepted including on the conference website.
The 2022 Neuroergonomics Conference and NYC Neuromodulation Conferences (July 28-August 1, 2022) are joined together to address the state-of-the-art in neurotechnology for brain-body performance and health. Neurotechnology represented at the conference spans extremes. From critical care, to well-being, to the brain in every-day life. From revolutionary invasive devices, to targeted non-invasive approaches, to wearables. From boosting the performance of athletes, surgeons, artists, first responders, to service members. From brain-to-brain interfaces to mixed/virtual reality, to social media.
This conference calls for abstract submissions that cover new approaches and emerging trends in all aspects of neuroergonomics and neuromodulation. Abstract submissions can be any approach including advanced neuroscience theories, methods and techniques, ethics, mechanistic studies, clinical trials, or neuroengineering approaches. An abstract that is intended to highlight a specific product without introducing new science and engineering or which otherwise appears to serve more marketing than science purposes, will not be considered appropriate. Abstracts can include content previously published or shared at another conference, as long as it is relevant to the 2022 Neuroergonomics and NYC Neuromodulation Conference audience.
Relevant topics include (but are not limited to):
- Invasive (SCS, VNS, DBS…) and Non-Invasive Neuromodulation (tDCS, tACS, tFUS, ECT, taVNS…)
- Invasive and Non-invasive Neuroimaging (fMRI, MEG, fNIRS, EEG, TCS, ECoG, PET, …) methods and applications
- Artificial Intelligence and the brain
- Neurotechnology and Ethics
- Technology for Addiction
- Invasive, and non-invasive Brain computer interface
- Brain-to-Brain Communication
- Neuro-Technology for Productivity or Creativity
- Eye-movement & Cognition: What the eyes reveal about the brain
- Virtual Reality and training the Brain and body
- Brain-to-Brain Communication
- Signal processing and machine learning techniques to sense the brain
- Physiological Markers of Brain Health
- Human-Automation Teaming
- Mental workload, engagement and human performance “in the wild”
- Training and skill acquisition
- Consumer Neuroergonomics and Neuromarketing
- Computer modeling of brain stimulation methods
- Closed-loop or responsive stimulation
- Combining brain stimulation methods with brain imaging
- Any combinations of the above
Check Status
Log in to your account to follow updates & get status updates
Log in
Abstracts Online
List of accepted abstracts
Browse
Abstract Format Instructions
Your submission must include the following sections:
Title - “What do you call this project/poster?”
Authors - List all authors.
Synopsis - A synopsis, limited to 800 characters, must be included for each abstract.
Your synopsis should include a brief summary of the problem, methods, results, and conclusions.
The synopsis must only include text, without equations or images, and be without references or
citations to items described in the full abstract. The synopsis should function as a stand-alone overview of your work (and may be published alone in the conference book).
Background - “Why was this study/research performed?” & “How has this problem been studied?” Limit 1600 characters
Methods - "What techniques and measures were used?" Limit 1600 characters
Results - “What was the outcome or principal data and statistical analysis?” Limit 3800 characters
Discussion - “What is the relevance to clinical practice or future research?” Limit 1600 characters.
References:
- Citations in the body of the paper - Cite each source in numerical order using Arabic numerals (1, 2, 3…).
- Citations in the reference list - List references numerically in the order by which they were cited in the text.
- Limit 3800 characters.
Figure -Figure - A maximum of one figure can be included in your submission and it must be in JPEG format. If is the submitters responsibility to ensure the figure is of sufficient high resolution and clarity. The figure cannot include figure legend in the JPEG. There is no special section for uploading a separate figure legend. Therefore any reference or text oescriotopn of the figure must be made in other component sections (Background, Methods, Results, Discussion…). The figure may include multiple panels. The overall figure size should generally correspond to no more than a 1/2 page figure (if published in a journal style layout), so less than 7.5” wide and less than 5” high.
Disclosure - Works submitted must include an acknowledgment of relevant funding sources of commercial nature and/or consulting or holding of significant equity in a company that could be affected by the results of the study. Other sources of funding should also be acknowledged. e.g. “funded by...” and/or “equity in...”.
If nothing to disclose, state “Nothing to disclose by any author(s).”
Disclosure of funding and/or relationships must not include company logos or other promotional material (text only).
Limit 2200 characters.
General Information
- There is no limit to the number of abstracts an author may submit for consideration. However, any individual can serve as presenting author on only one abstract.
- A presenting author of each abstract must register for the 2022 Neuroergonomics and NYC Neuromodulation Joint Conference. Submission of an abstract does not automatically register you for the conference.
- Abstracts submitted to, or presented at, other societies or national meetings or to journals may be submitted for consideration if you have retained copyright authority for any material submitted.
- All scientific research referred to, reported, or used in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection and analysis.
- All recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients.
- All submissions must be HIPAA-compliant. Patient confidentiality must be protected. No names, hospital ID numbers or any other identifying information can appear in your presentation.
- In submitting an abstract, all authors retain copyright to the content and agree to grant 2022 Neuroergonomics and NYC Neuromodulation Joint Conferences a limited, nonexclusive, royalty-free license to present and reproduce the content online, in print, and in other media or publications associated with its educational programs, and to archive the content online and in other means.
- Abstracts submitted without data, because investigations or analyses are incomplete, will be evaluated only on the basis of the information contained within the abstract.
- Reviewer scores and comments are confidential and will not be made available to anyone (including authors) outside of the immediate review process.
In order to be selected for an oral presentation, abstracts must:
- Receive high marks by the reviewers; and
- Represent innovative and recent work; and
- Align well with there overall themes of the conference.
Selection Process
Notification
The outcome of each abstract review can be checked on your dashboard via the Abstract Portal and will be emailed to the primary author listed within the abstract on a
rolling basis.
Review Criteria
- Innovation/Novelty - Advancement of knowledge, and/or improvement of capabilities.
- Quality - All recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. Data/outcomes should be substantive and not just implied. When possible, comprehensive statistical analysis should be applied. Images and spectra if provided should be of high quality.
- Impact - The method or data in the abstract should aim to advance or change the field or the behavior of clinicians in significant ways.
- Bias - Subjective Bias in favor of a particular product or company is grounds for rejection. Use of a particular company’s products or equipment in itself does not represent bias. Likewise, research involving a single method, drug, or device would not constitute bias if it conforms to best practices of study design and analysis. Non data-driven statements of superiority, however, would be considered biased.
- Repetition of Content - Multiple submissions to the conference of the same or nearly the same abstract by the same author(s)/institution(s) is grounds for rejection. However, multiple submissions of unique (related) content from the same author(s) is allowed.
- Clarity - Organization, presentation, structure, readability
- Tips: Proofread your abstract before submission. Minimize use of abbreviations. Type in sentence case.
Submitting Your Proposal
Due Date
May 27th, 2022 by 11:59 pm, ET
Include
- Authors
- 800-character Synopsis
- All Abstract sections
Authorization
The submitting author verifies, by virtue of submitting the abstract, that all authors agree:
- to the submission of the abstract to the 2022 Neuroergonomics with NYC Neuromodulation conference
- that copyright permissions have been secured (as necessary) for included material
- the abstract includes valid, accurate, and balanced content
- the abstract material may be published (online) by the 2022 Neuroergonomics with NYC Neuromodulation conference upon acceptance
- that content may be further published in a special issue of Frontiers in Neuroergonomics only if the author opts in at time of abstract submission.
Requirements
Submission of an abstract constitutes a commitment by the author(s) to present their work, if accepted.
A presenting author of each abstract must register for the 2022 Neuroergonomics with NYC Neuromodulation Joint Conference. Submission of an abstract does not automatically register you for the conference.
Expenses associated with the presentation of an abstract are the responsibility of the presenter. This includes the production of printed posters. However, poster boards and push pins will be available for poster presenters, and A/V will be provided for oral presentations.
If selected, your presentation/poster is expected to reflect the contents of your abstract.